New $1.9M DoD-Funded Trial Aims to Improve Swallow...
Category : Clinical Trial Update 25 November 2025Swallowing problems, or dysphagia, affect up to 80% of people with Parkinson’s disease. These...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Innocan Pharma Publishes Promising New Research on...
Category : Product Related Updates 25 November 2025Chronic pain management is stuck in an old loop—opioids, short-acting therapies, and inconsist...
Novo Nordisk’s Alzheimer’s Trials Miss Primary End...
Category : Clinical Trial Update 25 November 2025Alzheimer’s drug development is shifting. For decades, the field revolved around amyloid. Toda...
GEMMABio’s Next-Gen SMA1 Gene Therapy Cleared for...
Category : Clinical Trial Update 25 November 2025A major step forward for spinal muscular atrophy type 1 (SMA1) treatments is underway in Brazil. GEM...
PIPE-307 Misses Key Endpoints in RRMS: What Contin...
Category : Clinical Trial Update 24 November 2025Contineum Therapeutics has shared topline results from its Phase 2 VISTA trial of PIPE-307, an oral...
Latest Newsletter Post
-
GEMMABio’s Next-Gen SMA1 Gene Thera..
25 November 2025
-
Novo Nordisk’s Alzheimer’s Trials M..
25 November 2025
-
Innocan Pharma Publishes Promising..
25 November 2025
-
New $1.9M DoD-Funded Trial Aims to..
25 November 2025
-
Bayer Posts Positive Phase III Resu..
24 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com